Skip to main content
UniHealth

Doctor search

Daniel Garrett Vail, MD

Ophthalmology · Los Angeles

NPI 1285262568

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location

Looking this up.

Hospitals listed: UC San Diego Health Hillcrest - Hillcrest Med Ctr. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Vail’s office to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UC San Diego Health Hillcrest - Hillcrest Med CtrSan Diego, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Moores Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 75% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 105.39 (74.34 to 136.44) · 381 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.597, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.618, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.376, Oct 2024 – Sep 2025
See every measure and the patient survey for UC San Diego Health Hillcrest - Hillcrest Med Ctr

Behind the star rating — Deaths: 6 better, 2 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UC San Diego Health Hillcrest - Hillcrest Med Ctr
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths105.39 (74.34 to 136.44) · 381 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.597BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.618BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.375BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.376BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.83 (0.11 to 1.54) · 3,862 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.84 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.4 · 130 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.2 · 116 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.1 · 183 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.8 · 510 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11 · 696 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.4 · 435 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 5,739 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.15 (0 to 0.32) · 12,387 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.44) · 13,596 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.59 (3.24 to 5.94) · 4,389 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.04 (0 to 2.12) · 2,419 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.26 (1.23 to 3.29) · 4,116 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.93 (6.61 to 13.25) · 2,232 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.31 (5.24 to 9.38) · 2,410 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.32 (1.07 to 3.56) · 1,286 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.38 (0.02 to 0.75) · 11,838 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.5 · 181 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.716No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.672No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.5 · 302 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.3 · 891 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 216 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits5.9 · 620 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits12 · 731 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.7 · 946 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.9 (4.8 to 7) · 1,507 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.3 (10.7 to 14) · 1,507 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits7.1 · 191 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.7 · 177 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.7 · 204 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits10.4 (8.5 to 13) · 4,116 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1) · 2,130 casesNo differentJan 2024 – Dec 2024

What patients said (3,680 patients answered, 16% of those asked)

Patient survey stars by topic at UC San Diego Health Hillcrest - Hillcrest Med Ctr
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital4
Share of patients giving the best answer at UC San Diego Health Hillcrest - Hillcrest Med Ctr
Room was "always" clean66%
Nurses "always" communicated well79%
Doctors "always" communicated well79%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand75%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)73%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully75%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night49%
"YES", patients would definitely recommend the hospital75%
Staff "always" explained possible side effects48%
Yes, staff "did" give patients information about possible symptoms88%

Original Medicare doctor bills

$28,690

Medicare paid this office $28,690 for 191 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Established patient complete exam of visual system164$18,553$109
New patient complete exam of visual system13$1,691$130

Who their Medicare patients are

191 Original Medicare patients in 2024. Average age 77 · Women 61% · Also on Medicaid 14% · Health risk score 1.45. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 71% · Diabetes 29% · Coronary heart disease 26% · Chronic kidney disease 23% · Heart failure 19% · Atrial fibrillation 18% · Depression 17% · Cancer 16% · COPD 16% · Dementia 8% · Stroke 8%.

The office billed $141,104, Medicare allowed $36,303 and paid $28,690; for 337 services of 14 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Medicaid work

$749 in 2024

Medicaid paid $749 for 22 billed services this clinician did in 2024, up to 22 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST22$749
Medicaid work by year
202422122$749

Drugs they prescribed that Part D paid

$38,846

Pharmacies billed $38,846 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 383) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

203 generic and 180 brand-name prescriptions · $38,846 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Rhopressa37$11,926$322
Brimonidine52$3,174$61
Combigan12$2,864$239
Prednisolone Acetate63$1,811$29
Dorzolamide-Timolol50$719$14
See all 8 drugs
Every Part D drug this clinician prescribed
Rhopressa37$11,926$322
Brimonidine52$3,174$61
Combigan12$2,864$239
Prednisolone Acetate63$1,811$29
Dorzolamide-Timolol50$719$14
Moxifloxacin15$347$23
Ketorolac Tromethamine11$283$26
Latanoprost47$277$6

Year by year

Part D prescribing by year
20243831020% (0)47%$38,846
20234461420% (0)36%$51,781
20221,3082780% (0)38%$146,439
2021386960% (0)50%$46,529

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 9 drugs

Part D drugs prescribed in 2023
Restasis14$9,891$707
Rhopressa14$7,531$538
Brimonidine52$4,493$86
Dorzolamide-Timolol73$2,003$27
Prednisolone Acetate57$1,658$29
Latanoprost89$1,424$16
Moxifloxacin12$499$42
Dorzolamide11$452$41
Ketorolac Tromethamine17$386$23

2022: 16 drugs

Part D drugs prescribed in 2022
Rhopressa74$27,820$376
Restasis29$21,289$734
Brimonidine225$16,663$74
Lumigan32$11,502$359
Combigan24$10,231$426
Dorzolamide-Timolol218$8,003$37
Brinzolamide20$6,972$349
Latanoprost338$6,796$20
Alphagan P15$6,680$445
Prednisolone Acetate69$2,543$37
Pilocarpine30$2,376$79
Dorzolamide38$1,355$36
Valacyclovir15$511$34
Timolol Maleate37$384$10
Ketorolac Tromethamine15$340$23
Erythromycin16$152$10

2021: 8 drugs

Part D drugs prescribed in 2021
Rhopressa32$10,474$327
Brimonidine53$4,985$94
Lumigan15$3,376$225
Durezol11$2,335$212
Prednisolone Acetate34$1,836$54
Latanoprost72$1,521$21
Dorzolamide-Timolol40$1,461$37
Timolol Maleate17$149$9

Money from drug and device companies

$381 in 2025

Industry payments by year
202568None$381
202436None$1,193

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Mallinckrodt Hospital ProductsActhar$106
1 payment
  • Meals for Acthar · 2025-03-19 · $106
Astellas Pharma Global DevelopmentIzervay$79
1 payment
  • Meals for Izervay · 2025-10-01 · $79
Astellas Pharma USIzervay$67
2 payments
  • Meals for Izervay · 2025-09-16 · $35
  • Meals for Izervay · 2025-08-12 · $32
Bausch & Lomb AmericasXipere$58
1 payment
  • Meals for Xipere · 2025-10-22 · $58
AmgenTepezza$49
2 payments
  • Meals for Tepezza · 2025-06-04 · $27
  • Meals for Tepezza · 2025-04-23 · $22
AbbvieOzurdex$21
1 payment
  • Meals for Ozurdex · 2025-09-09 · $21
See all 8 published payments
Every published payment
Bausch & Lomb AmericasMeals · 2025-10-22Xipere$58
Astellas Pharma Global DevelopmentMeals · 2025-10-01Izervay$79
Astellas Pharma USMeals · 2025-09-16Izervay$35
AbbvieMeals · 2025-09-09Ozurdex$21
Astellas Pharma USMeals · 2025-08-12Izervay$32
AmgenMeals · 2025-06-04Tepezza$27
AmgenMeals · 2025-04-23Tepezza$22
Mallinckrodt Hospital ProductsMeals · 2025-03-19Acthar$106
See earlier years (2024)

2024: $1,193

Payments by company in 2024
Alcon VisionNone$1,044
4 payments
  • Travel · 2024-11-15 · $212
  • Travel · 2024-11-15 · $265
  • Travel · 2024-11-15 · $301
  • Meals · 2024-11-15 · $265
Regeneron Healthcare SolutionsEylea Hd$121
1 payment
  • Meals for Eylea Hd · 2024-09-26 · $121
AbbvieOzurdex$28
1 payment
  • Meals for Ozurdex · 2024-09-09 · $28

Professional record

NPI
1285262568
Trained
Stanford University School of Medicine, 2020
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
NPI first listed
2020-03-31
NPI last updated
2026-08-11
NPI record certified
2026-08-11

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 9300 Campus Point Dr, La Jolla, CA, 92037 · 9415 Campus Point Dr, La Jolla, CA, 92093 · 3020 Childrens Way, San Diego, CA, 92123 · 300 Pasteur Dr, Stanford, CA, 94305